Funding
Undisclosed · Biotech

Lightcast raises $27m for single-cell analysis

ARCH Venture Partners, M Ventures and other investors participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Lightcast raised $27 million in financing on April 14. Participants included ARCH Venture Partners, M Ventures, Illumina Ventures, +ND Capital, Longwall Ventures and OMX Ventures. The company develops functional single-cell analysis tools for life-science research.

Funding history

Undisclosed · This round$27M

Sources

  1. Lightcastprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related